Neutrophil adhesion to fibrinogen and fibrin under flow conditions is diminished by activation and L-selectin shedding. 1997

P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
Department of Hematology, University Hospital Utrecht, The Netherlands.

The adhesion of neutrophils (polymorphonuclear leukocytes [PMNs]) to immobilized fibrinogen/fibrin is mediated by beta2-integrins. However, the influence of physiologic flow conditions on neutrophil adhesion to these surfaces is poorly defined. In this report, the effect of flow and neutrophil activation on adhesion to immobilized fibrinogen and fibrin was examined. For the evaluation of (the distribution of) neutrophil adhesion, real-time video-assisted microscopy and custom-made software were used. Under flow conditions, adherent neutrophils appeared to support the subsequent margination of other neutrophils, thereby enhancing the adherence of these cells to fibrin. Consequently, neutrophils adhered in clusters, especially at higher shear stresses (eg, cluster index 1.4 at shear 80 mPa). Preactivation of PMNs with fMLP (10(-7) mol/L) or 4beta-phorbol, 12-myristate, 13-acetate (PMA; 100 ng/mL) resulted in approximately 50% inhibition of adhesion to fibrin and a more random distribution (cluster index <0.5). L-selectin antibodies or neuraminidase treatment of PMNs also inhibited adhesion and clustering, indicating a role for L-selectin. Under static conditions, no clustering appeared and PMN activation with fMLP or PMA caused threefold and sevenfold increased adhesion, respectively. Under these conditions, anti-L-selectin antibodies or neuraminidase did not affect adhesion. These results indicate that, under flow conditions, adherent neutrophils support adhesion of flowing neutrophils by L-selectin-mediated cell-cell interactions. Preactivated neutrophils, with lowered L-selectin expression, are less susceptible for this interaction. By this mechanism, adhered leukocytes can modulate the recruitment of leukocytes to the vessel wall at sites of inflammation.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002449 Cell Aggregation The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type. Aggregation, Cell,Aggregations, Cell,Cell Aggregations
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016028 Receptors, Leukocyte-Adhesion Family of proteins associated with the capacity of LEUKOCYTES to adhere to each other and to certain substrata, e.g., the C3bi component of complement. Members of this family are the LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; (LFA-1), the MACROPHAGE-1 ANTIGEN; (Mac-1), and the INTEGRIN ALPHAXBETA2 or p150,95 leukocyte adhesion protein. They all share a common beta-subunit which is the CD18 antigen. All three of the above antigens are absent in inherited LEUKOCYTE-ADHESION DEFICIENCY SYNDROME, which is characterized by recurrent bacterial infections, impaired pus formation, and wound healing as well as abnormalities in a wide spectrum of adherence-dependent functions of granulocytes, monocytes, and lymphoid cells. Leu-CAM Receptor Family,Leukocyte-Adhesion Receptors,Leukocyte-Adhesion Receptor,Leukocyte-Adhesion Receptor Family,Family, Leu-CAM Receptor,Leu CAM Receptor Family,Leukocyte Adhesion Receptor,Leukocyte Adhesion Receptor Family,Leukocyte Adhesion Receptors,Receptor Family, Leu-CAM,Receptor, Leukocyte-Adhesion,Receptors, Leukocyte Adhesion
D018056 Hemorheology The deformation and flow behavior of BLOOD and its elements i.e., PLASMA; ERYTHROCYTES; WHITE BLOOD CELLS; and BLOOD PLATELETS. Hemorrheology
D018375 Neutrophil Activation The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonized particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil. Activation, Neutrophil,Activations, Neutrophil,Neutrophil Activations
D019041 L-Selectin Cell adhesion molecule and CD antigen that serves as a homing receptor for lymphocytes to lymph node high endothelial venules. Antigens, CD62L,CD62L Antigens,LECAM-1,CD62L Antigen,L Selectin,LAM-1,Leu-8 Antigen,Leukocyte Adhesion Molecule, LAM-1,Mel-14 Antigen,TQ1 Antigen,Antigen, CD62L,Antigen, Leu-8,Antigen, Mel-14,Antigen, TQ1,Leu 8 Antigen,Leukocyte Adhesion Molecule, LAM 1,Mel 14 Antigen,Selectin, L

Related Publications

P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
July 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
October 2013, The Journal of experimental medicine,
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
March 2003, The Journal of biological chemistry,
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
January 2009, Microcirculation (New York, N.Y. : 1994),
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
September 1994, Journal of immunology (Baltimore, Md. : 1950),
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
February 2007, The Journal of biological chemistry,
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
August 1984, Journal of cell science,
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
August 1994, Blood,
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
April 1996, Nature,
P H Kuijper, and H I Gallardo Torres, and J A van der Linden, and J W Lammers, and J J Sixma, and J J Zwaginga, and L Koenderman
May 1997, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!